Quick Answer
AXIM BIOTECHNOLOGIES, INC. reported Total Revenue of $39.5 thousand for fiscal year 2023.
AXIM BIOTECHNOLOGIES, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2023 | $39.5K | +345.3% |
| 2022 | $8.9K | -85.3% |
| 2021 | $60.5K | -69.1% |
| 2018 | $195.6K | +311.2% |
| 2017 | $47.6K | +1.1% |
| 2016 | $47.1K | +117.2% |
| 2013 | $21.7K | -50.0% |
| 2012 | $43.3K | +333.3% |
| 2011 | $10.0K | — |
| 2010 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $17.5K | +76.0% | -67.0% |
| March 31, 2024 | $53.0K | +616.2% | +453.0% |
| September 30, 2023 | $9.6K | +629.1% | -3.5% |
| June 30, 2023 | $9.9K | — | +34.2% |
| March 31, 2023 | $7.4K | — | +462.9% |
| September 30, 2022 | $1.3K | -83.8% | — |
| June 30, 2022 | $0.00 | -100.0% | — |
| March 31, 2022 | $0.00 | -100.0% | -100.0% |
- AXIM BIOTECHNOLOGIES, INC. showed an increase of +345.3% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from AXIM BIOTECHNOLOGIES, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: